Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of CartiLife for Knee Chondral Defects
NCT03517046Phase 1Completed
- Sponsor
- Biosolution Co., Ltd.
- Start
- Jul 2012
- Primary completion
- Dec 2013
- Modality
- Tissue Cells
01
Overview
Phase 1, open-label trial of CartiLife in articular cartilage lesion of the knee (2 arms), sponsored by Biosolution Co., Ltd. Primary endpoint: Adverse events at 48 weeks. Started Jul 2012; status: completed.
02
Drugs
CartiLife
03
Conditions
articular cartilage lesion of the knee
Beyond the preview
Go deeper on NCT03517046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03517046.